Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Alzheimer's PET Imaging in Racially/Ethnically Diverse Adults

Trial Profile

Alzheimer's PET Imaging in Racially/Ethnically Diverse Adults

Phase of Trial: Phase I

Latest Information Update: 18 Jan 2019

At a glance

  • Drugs Fluorine-18-MK 6240 (Primary) ; Florbetaben F18
  • Indications Alzheimer's disease; Neurodegenerative disorders
  • Focus Diagnostic use
  • Most Recent Events

    • 10 Jan 2019 Status changed from not yet recruiting to recruiting.
    • 23 Oct 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top